Abstract:Background: Odontogenic keratocysts (OKCs) are odontogenic jaw lesions that cause destruction and dysfunction of the jawbone. OKCs can be sporadic or associated with nevoid basic cell carcinoma syndrome (NBCCS). However, the factors that initiate OKCs and the mechanism of cyst formation remain unclear. Here, we investigated the impact of PTCH1 and SMO mutations on disease progression, as well as the effects of sonic hedgehog (SHH) signaling pathway inhibitors GDC-0449 and GANT61 on OKC fibroblasts. Methods: Eight sporadic OKC fibroblasts without gene mutations were used as the control, and six NBCCS-related fibroblasts were cultured in vitro. The effect of PTCH1 non-truncated mutation 3499G>A (p.G1167R) and SMO c.2081C>G (p.P694R) mutation on OKC fibroblast proliferation was examined by EdU assay. CCK8 and wound-healing assays detected the effects of OKC fibroblasts carrying PTCH1 c.3499G>A (p.G1167R) and SMO c.2081C>G (p.P694R) mutations on the proliferation and migration of HaCaT cells after co-culture. Quantitative real-time PCR detected the effects of GDC-0449 or GANT61 on the SHH signaling pathway in NBCCS-related OKCs with PTCH1 truncated mutations and PTCH1 c.3499G>A (p.G1167R) and/or SMO c.2081C>G (p.P694R) mutations. Results: PTCH1 c.3499G>A (p.G1167R) and SMO c.2081C>G (p.P694R) promoted the proliferation of OKC fibroblasts. The proliferation and migration of HaCaT cells were affected by NBCCS-related OKC fibroblasts carrying PTCH1 c.3499G>A (p.G1167R) and SMO c.2081C>G (p.P694R) mutations. GDC-0449 significantly inhibited the SHH signaling pathway in NBCCS-related OKC fibroblasts with PTCH1 truncated mutations. An NBCCS-related OKC carrying PTCH1 c.3499G>A (p.G1167R) and SMO c.2081C>G (p.P694R) mutations were resistant to GDC-0449 but inhibited by GANT61. Conclusions: Genetic mutations in OKC fibroblasts may affect the biological behavior of epithelial and stromal cells and cause disease. GDC-0449 could be used to treat OKCs, especially NBCCS-related OKCs with PTCH1 truncated mutations. SMO c.2081C>G (p.P694R) may lead to resistance to GDC-0449; however, GANT61 may be used as an alternative inhibitor.

PTCH mutations in sporadic and Gorlin-syndrome-related odontogenic keratocysts.

One germline mutation of PTCH gene in a Chinese family with non-syndromic keratocystic odontogenic tumours.

PTCH1 Gene Mutations in Keratocystic Odontogenic Tumors: A Study of 43 Chinese Patients and a Systematic Review

[PTCH Gene Mutations in Odontogenic Keratocysts].

Detection of PTCH gene mutations in odontogenic keratocysts by SSCP and DNA sequencing]

Identification of Known and Novel PTCH Mutations in Both Syndromic and Non-syndromic Keratocystic Odontogenic Tumors

PTCH Germline Mutations in Chinese Nevoid Basal Cell Carcinoma Syndrome Patients.

PTCH1 and SMO gene alterations in keratocystic odontogenic tumors.

Further Expanding the Mutational Spectrum of Gorlin Syndrome in Three Unrelated Families

Underestimated PTCH1 Mutation Rate in Sporadic Keratocystic Odontogenic Tumors.

[PTCH2 Gene Alterations in Keratocystic Odontogenic Tumors Associated with Nevoid Basal Cell Carcinoma Syndrome].

PTCH1 mutations in odontogenic keratocysts: are they related to epithelial cell proliferation?

[Studies on Keratocystic Odontogenic Tumors].

Germline PTCH1: c.361_362insAlu alteration identified by comprehensive exome and RNA sequencing in a patient with Gorlin syndrome

PTCH1 Alterations Are Frequent but Other Genetic Alterations Are Rare in Sporadic Odontogenic Keratocysts

PTCH/SMO gene mutations in odontogenic keratocysts and drug interventions

Gorlin-Like Phenotype in a Young Girl With a De Novo PTCH2 Variant Mutation of Uncertain Significance

The relationship between polymorphism of PTCH gene and sporadic keratocystic odontogenic tumor

Orthokeratinized Odontogenic Cysts: A Clinicopathologic Study of 159 Cases and Molecular Evidence for the Absence of PTCH1 Mutations

Mechanisms of Inactivation of PTCH1 Gene in Nevoid Basal Cell Carcinoma Syndrome: Modification of the Two-Hit Hypothesis

Case Report: Papillary thyroid carcinoma in Goltz-Gorlin syndrome